Antimicrobial resistance in ESKAPE pathogens

DMP De Oliveira, BM Forde, TJ Kidd… - Clinical microbiology …, 2020 - Am Soc Microbiol
Antimicrobial-resistant ESKAPE (E nterococcus faecium, S taphylococcus aureus, K
lebsiella pneumoniae, A cinetobacter baumannii, P seudomonas aeruginosa, and E …

Updates on the pathogenicity status of Pseudomonas aeruginosa

MW Azam, AU Khan - Drug discovery today, 2019 - Elsevier
Highlights•MDR P. aeruginosa is one of the major causes of the nosocomial
infections.•Virulence factors involved in pathogenicity were described.•Potential inhibitors of …

Infections caused by resistant gram‐negative bacteria: epidemiology and management

KS Kaye, JM Pogue - Pharmacotherapy: The Journal of Human …, 2015 - Wiley Online Library
Infections caused by resistant gram‐negative bacteria are becoming increasingly prevalent
and now constitute a serious threat to public health worldwide because they are difficult to …

Nosocomial Infections Due to Multidrug‐Resistant Pseudomonas aeruginosa: Epidemiology and Treatment Options

MD Obritsch, DN Fish, R MacLaren… - … : The Journal of Human …, 2005 - Wiley Online Library
Pseudomonas aeruginosa is one of the leading gram‐negative organisms associated with
nosocomial infections. The increasing frequency of multi‐drug‐resistant Pseudomonas …

The Epidemiological Profile of Infections with Multidrug-Resistant Pseudomonas aeruginosa and Acinetobacter Species

DL Paterson - Clinical infectious diseases, 2006 - academic.oup.com
Isolates of Pseudomonas aeruginosa or Acinetobacter species that are resistant to all, or
almost all, commercially available antibiotics are now prevalent worldwide. Typically, these …

Acquisition of 16S rRNA methylase gene in Pseudomonas aeruginosa

K Yokoyama, Y Doi, K Yamane, H Kurokawa… - The lancet, 2003 - thelancet.com
Background Bacteria develop resistance to aminoglycosides by producing aminoglycoside-
modifying enzymes such as acetyltransferase, phosphorylase, and adenyltransferase …

Gram-negative antibiotic resistance: there is a price to pay

TG Slama - Critical Care, 2008 - Springer
Resistance rates are increasing among several problematic Gram-negative pathogens that
are often responsible for serious nosocomial infections, including Acinetobacter spp …

Hospital costs of nosocomial multi-drug resistant Pseudomonas aeruginosa acquisition

E Morales, F Cots, M Sala, M Comas, F Belvis… - BMC health services …, 2012 - Springer
Background We aimed to assess the hospital economic costs of nosocomial multi-drug
resistant Pseudomonas aeruginosa acquisition. Methods A retrospective study of all hospital …

[HTML][HTML] Virulence gene profiles of multidrug-resistant Pseudomonas aeruginosa isolated from Iranian hospital infections

N Fazeli, H Momtaz - Iranian Red Crescent Medical Journal, 2014 - ncbi.nlm.nih.gov
Background: The most common hospital-acquired pathogen is Pseudomonas aeruginosa. It
is a multidrug resistant bacterium causing systemic infections. Objectives: The present study …

Paeonol Attenuates Quorum-Sensing Regulated Virulence and Biofilm Formation in Pseudomonas aeruginosa

D Yang, S Hao, L Zhao, F Shi, G Ye, Y Zou… - Frontiers in …, 2021 - frontiersin.org
With the prevalence of multidrug-resistant bacteria and clinical-acquired pathogenic
infections, the development of quorum-sensing (QS) interfering agents is one of the most …